BioSpace News Archive

Business

Petauri™ Welcomes Mridul Malhotra

Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced that it has named Mridul Malhotra to the dual role of Chief Strategic Officer and Global Head: Evidence, Value, and Access.

July 12, 2023
·
3 min read
Deals

Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston

Apollo Medical Holdings, Inc. announced that it and its affiliated professional entity have entered into a definitive agreement to acquire assets relating to Texas Independent Providers, LLC.

July 12, 2023
·
4 min read
Biotech Beach

DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, announced a favorable coverage policy from Highmark Inc.

July 12, 2023
·
5 min read
Business

Syncromune® Inc., Appoints Jonathan Lewis, M.D., Ph.D., A Renowned Immune Therapy Pioneer, as Chief Medical Officer

Syncromune ® Inc., Appoints Jonathan Lewis, M.D., Ph.D., A Renowned Immune Therapy Pioneer, as Chief Medical Officer.

July 12, 2023
·
7 min read
Drug Development

Direct Biologics Announces Publication of Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Controlled Clinical Trial in the Journal CHEST

Direct Biologics Announces Publication of Significant Survival Benefit with ExoFlo ™ in its Phase 2 Randomized Controlled Clinical Trial in the Journal CHEST.

July 12, 2023
·
4 min read
Business

Revvity to Hold Earnings Call on Tuesday, August 1, 2023

Revvity (NYSE: RVTY), today announced that it will release its second quarter 2023 financial results prior to market open on Tuesday, August 1, 2023.

July 12, 2023
·
1 min read
Business

Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its second quarter 2023 financial results on Wednesday, August 2, 2023.

July 12, 2023
·
1 min read
BioMidwest

Eyas™ Medical Imaging Brings State-of-the-Art MRI to NICUs, Revolutionizing Access for Fragile Newborns

Eyas Medical Imaging is proud to announce the first installation of the groundbreaking neonatal Magnetic Resonance Imaging system, the Ascent3T™, within the neonatal intensive care unit at Cincinnati Children’s.

July 12, 2023
·
7 min read
Biotech Bay

Spectacular Labs Unveils Future of Food Safety Testing

Spectacular Labs Inc., an innovator of next-generation rapid pathogen testing, announced that it will be showcasing its groundbreaking technology for the first time at the upcoming International Association for Food Protection 2023 Annual Meeting.

July 12, 2023
·
3 min read
Lone Star Bio

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer

bioAffinity Technologies, Inc. announced that the American Medical Association has released a Current Procedural Terminology code specifically for use with CyPath® Lung, a noninvasive test for early-stage lung cancer.

July 12, 2023
·
5 min read